Clinical Trials Browser

Phase 2 × INDUSTRY × Dosage Forms × Clear all

NCT00042341 2022-05-27

Phase II Study of Clofarabine in Pediatric Acute Lymphoblastic Leukemia (ALL)

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00042354 2015-03-05

Phase II Study of Clofarabine in Pediatric Acute Myelogenous Leukemia (AML) Patients

Phase 2 Completed

Other hematologic neoplasm

Leukemia

NCT00044889 2014-03-19

Phase II Study of Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute